4596 Stock Overview
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Kubota Pharmaceutical Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥70.00 |
| 52 Week High | JP¥112.00 |
| 52 Week Low | JP¥67.00 |
| Beta | 1.1 |
| 1 Month Change | -9.09% |
| 3 Month Change | -10.26% |
| 1 Year Change | -34.58% |
| 3 Year Change | -72.44% |
| 5 Year Change | -84.88% |
| Change since IPO | -96.90% |
Recent News & Updates
Shareholder Returns
| 4596 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -1.4% | 2.7% | 1.8% |
| 1Y | -34.6% | 4.7% | 31.0% |
Return vs Industry: 4596 underperformed the JP Pharmaceuticals industry which returned 4.7% over the past year.
Return vs Market: 4596 underperformed the JP Market which returned 31% over the past year.
Price Volatility
| 4596 volatility | |
|---|---|
| 4596 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4596's share price has been volatile over the past 3 months.
Volatility Over Time: 4596's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 12 | Ryo Kubota | www.kubotaholdings.co.jp |
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices; and wearable device for myopia control.
Kubota Pharmaceutical Holdings Co., Ltd. Fundamentals Summary
| 4596 fundamental statistics | |
|---|---|
| Market cap | JP¥3.94b |
| Earnings (TTM) | -JP¥1.49b |
| Revenue (TTM) | JP¥39.00m |
101.0x
P/S Ratio-2.6x
P/E RatioIs 4596 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4596 income statement (TTM) | |
|---|---|
| Revenue | JP¥39.00m |
| Cost of Revenue | JP¥12.00m |
| Gross Profit | JP¥27.00m |
| Other Expenses | JP¥1.52b |
| Earnings | -JP¥1.49b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | -26.45 |
| Gross Margin | 69.23% |
| Net Profit Margin | -3,817.95% |
| Debt/Equity Ratio | 0% |
How did 4596 perform over the long term?
See historical performance and comparison